| Literature DB >> 22319609 |
Graciliana Lopes1, Carla Sousa, Luís R Silva, Eugénia Pinto, Paula B Andrade, João Bernardo, Teresa Mouga, Patrícia Valentão.
Abstract
Bacterial and fungal infections and the emerging multidrug resistance are driving interest in fighting these microorganisms with natural products, which have generally been considered complementary to pharmacological therapies. Phlorotannins are polyphenols restricted to brown seaweeds, recognized for their biological capacity. This study represents the first research on the antibacterial, antifungal, anti-inflammatory and antioxidant activity of phlorotannins purified extracts, which were obtained from ten dominant brown seaweeds of the occidental Portuguese coast.Phlorotannins content was determined by the specific dimethoxybenzaldehyde (DMBA) method and a yield between 75 and 969 mg/Kg phloroglucinol units (dry matter) was obtained. Fucus spiralis ranked first, followed by three Cystoseira species. The anti-inflammatory potential of the purified extracts was assessed via inhibitory effect on nitric oxide (NO) production by lipopolysaccharide-stimulated RAW 264.7 macrophage cells, Cystoseira tamariscifolia being the one showing promising activity for the treatment of inflammation. NO scavenging ability was also addressed in cell free systems, F. spiralis being the species with highest capacity. The antimicrobial potential of the extracts was checked against five Gram-positive and four Gram-negative bacteria and three fungi strains, that commonly colonize skin and mucosa and are responsible for food contamination. The different extracts were more effective against Gram-positive bacteria, Staphylococcus epidermidis being the most susceptible species. Concerning antifungal activity, Trichophyton rubrum was the most sensitive species.Although the molecular mechanisms underlying these properties remain poorly understood, the results obtained turn phlorotannins purified extracts a novel and potent pharmacological alternative for the treatment of a wide range of microbial infections, which usually also present an inflammatory component. In addition to the biological properties demonstrated herein, phlorotannins extracts may also be preferred, in order to avoid side effects and allergic reactions commonly associated with synthetic drugs.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22319609 PMCID: PMC3271118 DOI: 10.1371/journal.pone.0031145
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Chemical structures of different types of phlorotannins.
Phloroglucinol (1), Tetrafucol A (2), Tetraphlorethol B (3), Fucodiphlorethol A (4), Tetrafuhalol A (5), Tetraisofuhalol (6), and Phlorofucofuroeckol (7).
Figure 2Phylogenetic representation of the seaweeds species studied.
Phlorotannins content of brown seaweeds.
| Sample | Phlorotannins (mg/Kg) |
|
| 81.64 (1.57) |
|
| 516.24 (3.15) |
|
| 815.82 (17.46) (50,59349441) |
|
| 288.20 (8.01) |
|
| 968.57 (10.89) |
|
| 101.97 (1.57) |
|
| 53.31 (1.57) |
|
| 36.68 (1.82) |
|
| 74.96 (7.76) |
|
| 126.73 (0.91) |
Mean (Standard Deviation) of three determinations, expressed as phloroglucinol units.
Figure 3Effect of phlorotannins purified extracts on LPS-induced NO production in RAW 264.7 cells.
Values of each group are expressed as % of LPS-only exposed cells (mean ± SEM of 4 independent assays). *p<0.05, **p<0.01, ***p<0.001.
Figure 4Effect of phlorotannins purified extracts on SNP-generated NO in a cell-free system.
Values of each group are expressed as % of control (mean ± SEM of 4 independent assays). *p<0.05, **p<0.01, ***p<0.001.
MIC and MLC of phlorotannins purified extracts against selected bacteria.
| Gram-positive | Gram-negative | |||||||||||||||||
| Seaweed Extract |
|
|
|
|
|
|
|
|
| |||||||||
| MIC | MLC | MIC | MLC | MIC | MLC | MIC | MLC | MIC | MLC | MIC | MLC | MIC | MLC | MIC | MLC | MIC | MLC | |
|
| >31.3 | - | 31.3 | >31.3 | >31.3 | - | >31.3 | - | >31.3 | - | >31.3 | - | >31.3 | - | >31.3 | - | >31.3 | - |
|
| 7.8 | >31.3 | 3.9 | 31.3 | 15.6 | 31.3 | >31.3 | - | 15.6 | >31.3 | 15.6 | >31.3 | 31.3 | 31.3 | 31.3 | >31.3 | 31.3 | >31.3 |
|
| 15.6 | >31.3 | 7.8 | >31.3 | 15.6 | 31.3 | >31.3 | - | 15.6 | >31.3 | 31.3 | >31.3 | >31.3 | - | >31.3 | - | >31.3 | - |
|
| 15.6 | >31.3 | 7.8 | >31.3 | 31.3 | >31.3 | >31.3 | - | 31.3 | >31.3 | 31.3 | >31.3 | >31.3 | - | >31.3 | - | >31.3 | - |
|
| 7.8 | >31.3 | 3.9 | 31.3 | 2.0 | 15.6 | 15.6 | 31.3 | 7.8 | 31.3 | 31.3 | >31.3 | >31.3 | - | 31.3 | >31.3 | >31.3 | - |
|
| >31.3 | - | 31.3 | >31.3 | >31.3 | - | >31.3 | - | >31.3 | - | >31.3 | - | >31.3 | - | >31.3 | - | >31.3 | - |
|
| >31.3 | - | 15.6 | >31.3 | >31.3 | - | >31.3 | - | >31.3 | - | >31.3 | - | >31.3 | - | >31.3 | - | >31.3 | - |
|
| >31.3 | - | 15.6 | >31.3 | >31.3 | - | >31.3 | - | >31.3 | - | >31.3 | - | >31.3 | - | >31.3 | - | >31.3 | - |
|
| 31.3 | >31.3 | 7.8 | >31.3 | >31.3 | - | 31.3 | >31.3 | >31.3 | - | 31.3 | >31.3 | >31.3 | - | >31.3 | - | >31.3 | - |
|
| >31.3 | - | 31.3 | >31.3 | >31.3 | - | >31.3 | - | >31.3 | - | >31.3 | - | >31.3 | - | >31.3 | - | >31.3 | - |
mg/mL (dry matter).
MIC and MLC of phlorotannins purified extracts against selected fungi.
| Fungi | ||||||
| Seaweed Extract |
|
|
| |||
| MIC | MLC | MIC | MLC | MIC | MLC | |
|
| >31.3 | - | >31.3 | - | >31.3 | - |
|
| 7.8 | >31.3 | >31.3 | - | 3.9 | 7.8 |
|
| >31.3 | - | >31.3 | - | 31.3 | >31.3 |
|
| 31.3 | >31.3 | >31.3 | - | 7.8 | 31.3 |
|
| 31.3 | >31.3 | >31.3 | - | 3.9 | 31.3 |
|
| >31.3 | - | >31.3 | - | >31.3 | - |
|
| >31.3 | - | >31.3 | - | >31.3 | - |
|
| >31.3 | - | >31.3 | - | >31.3 | - |
|
| 15.6–31.3 | >31.3 | >31.3 | - | 7.8 | 31.3 |
|
| >31.3 | - | >31.3 | - | >31.3 | - |
mg/mL (dry matter).